DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Gevaert P. et al.
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
The Journal of allergy and clinical immunology 2020;
146 (03) 595-605
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.